DK1177195T3 - 1-Aminotriazolo[4,3-a]quinazolin-5-oner og/eller -5-thioner, der inhiberer phosphodiesterase IV - Google Patents
1-Aminotriazolo[4,3-a]quinazolin-5-oner og/eller -5-thioner, der inhiberer phosphodiesterase IVInfo
- Publication number
- DK1177195T3 DK1177195T3 DK00967407T DK00967407T DK1177195T3 DK 1177195 T3 DK1177195 T3 DK 1177195T3 DK 00967407 T DK00967407 T DK 00967407T DK 00967407 T DK00967407 T DK 00967407T DK 1177195 T3 DK1177195 T3 DK 1177195T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminotriazolo
- thiones
- quinazolin
- ones
- inhibit phosphodiesterase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905398A FR2792938B1 (fr) | 1999-04-28 | 1999-04-28 | NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV |
PCT/FR2000/001174 WO2000066584A1 (fr) | 1999-04-28 | 2000-04-28 | 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES ET/OU -5-THIONES INHIBITRICES DE PHOSPHODIESTERASES IV |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1177195T3 true DK1177195T3 (da) | 2003-07-14 |
Family
ID=9544983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00967407T DK1177195T3 (da) | 1999-04-28 | 2000-04-28 | 1-Aminotriazolo[4,3-a]quinazolin-5-oner og/eller -5-thioner, der inhiberer phosphodiesterase IV |
Country Status (34)
Country | Link |
---|---|
US (1) | US6828315B1 (da) |
EP (1) | EP1177195B1 (da) |
JP (1) | JP2002543199A (da) |
KR (1) | KR20020008166A (da) |
CN (1) | CN1352644A (da) |
AP (1) | AP2001002309A0 (da) |
AT (1) | ATE234840T1 (da) |
AU (1) | AU4411500A (da) |
BG (1) | BG106026A (da) |
BR (1) | BR0010072A (da) |
CA (1) | CA2388658A1 (da) |
DE (1) | DE60001735T2 (da) |
DK (1) | DK1177195T3 (da) |
DZ (1) | DZ3154A1 (da) |
EA (1) | EA004373B1 (da) |
EE (1) | EE200100566A (da) |
ES (1) | ES2194779T3 (da) |
FR (1) | FR2792938B1 (da) |
HK (1) | HK1044938B (da) |
HR (1) | HRP20010794B1 (da) |
HU (1) | HUP0202656A3 (da) |
IL (1) | IL146178A0 (da) |
IS (1) | IS6114A (da) |
MA (1) | MA27343A1 (da) |
MX (1) | MXPA01010888A (da) |
NO (1) | NO20015235L (da) |
OA (1) | OA11875A (da) |
PL (1) | PL351951A1 (da) |
PT (1) | PT1177195E (da) |
SK (1) | SK15322001A3 (da) |
TR (1) | TR200103099T2 (da) |
WO (1) | WO2000066584A1 (da) |
YU (1) | YU76401A (da) |
ZA (1) | ZA200108847B (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
PA8539501A1 (es) * | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Compuestos triazolo como inhibidores de mmp |
CN1520313A (zh) * | 2001-05-23 | 2004-08-11 | ������ҩ��ʽ���� | 一种加速骨折愈合的组合物 |
EP1285922A1 (en) * | 2001-08-13 | 2003-02-26 | Warner-Lambert Company | 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
FR2832711B1 (fr) * | 2001-11-26 | 2004-01-30 | Warner Lambert Co | Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation |
DE10229778A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Neue Verwendung von Imidazotriazinonen |
WO2004041819A1 (ja) * | 2002-11-06 | 2004-05-21 | Grelan Pharmaceutical Co., Ltd. | ピラゾロナフチリジン誘導体 |
ES2291729T7 (es) | 2003-01-09 | 2010-03-31 | Astellas Pharma Inc. | Derivados de pirrolopiridazina. |
ZA200609228B (en) * | 2004-04-23 | 2008-05-28 | Celgene Corp | Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
EP1942879A1 (en) | 2005-10-31 | 2008-07-16 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5ht受容体介在性の神経新生 |
BRPI0716604A2 (pt) | 2006-09-08 | 2013-04-09 | Braincells Inc | combinaÇÕes contendo um derivado de 4-acilaminopiridina |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2663436A1 (en) | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
WO2009013286A1 (en) * | 2007-07-24 | 2009-01-29 | Novartis Ag | Organic compounds |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN103224498B (zh) * | 2013-05-07 | 2015-10-28 | 陈定奔 | 两种唑并喹唑啉酮稠杂环的新合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865824A (en) * | 1972-03-07 | 1975-02-11 | Icn Pharmaceuticals | 2-Aryl-7-substituted pyrazolo {8 1,5{i a{b {9 1,3,5-triazines |
US3850932A (en) * | 1973-06-28 | 1974-11-26 | Sandoz Ag | 5-(2-carboxy and 2-carboalkoxy-phenylamino)-1,2,4-triazolo-quinazolines |
IL66835A (en) * | 1981-09-24 | 1988-05-31 | Roussel Uclaf | 1,4-disubstituted(1,2,4)triazolo(4,3-alpha)quinazolin-5(4h)-one derivatives and their salts,their preparation and pharmaceutical compositions containing them |
JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
SK282167B6 (sk) * | 1995-06-06 | 2001-11-06 | Pfizer Inc. | Tricyklické 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a] pyridíny a farmaceutický prostriedok na ich báze |
ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
-
1999
- 1999-04-28 FR FR9905398A patent/FR2792938B1/fr not_active Expired - Lifetime
-
2000
- 2000-04-28 EE EEP200100566A patent/EE200100566A/xx unknown
- 2000-04-28 AP APAP/P/2001/002309A patent/AP2001002309A0/en unknown
- 2000-04-28 WO PCT/FR2000/001174 patent/WO2000066584A1/fr active Search and Examination
- 2000-04-28 US US09/980,540 patent/US6828315B1/en not_active Expired - Fee Related
- 2000-04-28 CN CN00808153A patent/CN1352644A/zh active Pending
- 2000-04-28 HU HU0202656A patent/HUP0202656A3/hu unknown
- 2000-04-28 OA OA1200100282A patent/OA11875A/fr unknown
- 2000-04-28 DK DK00967407T patent/DK1177195T3/da active
- 2000-04-28 PL PL00351951A patent/PL351951A1/xx not_active Application Discontinuation
- 2000-04-28 AU AU44115/00A patent/AU4411500A/en not_active Abandoned
- 2000-04-28 AT AT00967407T patent/ATE234840T1/de not_active IP Right Cessation
- 2000-04-28 YU YU76401A patent/YU76401A/sh unknown
- 2000-04-28 JP JP2000615614A patent/JP2002543199A/ja active Pending
- 2000-04-28 PT PT00967407T patent/PT1177195E/pt unknown
- 2000-04-28 EA EA200100994A patent/EA004373B1/ru not_active IP Right Cessation
- 2000-04-28 CA CA002388658A patent/CA2388658A1/en not_active Abandoned
- 2000-04-28 BR BR0010072-2A patent/BR0010072A/pt not_active IP Right Cessation
- 2000-04-28 DZ DZ003154A patent/DZ3154A1/xx active
- 2000-04-28 TR TR2001/03099T patent/TR200103099T2/xx unknown
- 2000-04-28 ES ES00967407T patent/ES2194779T3/es not_active Expired - Lifetime
- 2000-04-28 IL IL14617800A patent/IL146178A0/xx unknown
- 2000-04-28 KR KR1020017013825A patent/KR20020008166A/ko not_active Application Discontinuation
- 2000-04-28 SK SK1532-2001A patent/SK15322001A3/sk unknown
- 2000-04-28 EP EP00967407A patent/EP1177195B1/fr not_active Expired - Lifetime
- 2000-04-28 MX MXPA01010888A patent/MXPA01010888A/es active IP Right Grant
- 2000-04-28 DE DE60001735T patent/DE60001735T2/de not_active Expired - Fee Related
-
2001
- 2001-10-18 BG BG106026A patent/BG106026A/bg unknown
- 2001-10-19 IS IS6114A patent/IS6114A/is unknown
- 2001-10-23 MA MA26381A patent/MA27343A1/fr unknown
- 2001-10-26 ZA ZA200108847A patent/ZA200108847B/xx unknown
- 2001-10-26 HR HR20010794A patent/HRP20010794B1/xx not_active IP Right Cessation
- 2001-10-26 NO NO20015235A patent/NO20015235L/no not_active Application Discontinuation
-
2002
- 2002-08-05 HK HK02105712.4A patent/HK1044938B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1177195T3 (da) | 1-Aminotriazolo[4,3-a]quinazolin-5-oner og/eller -5-thioner, der inhiberer phosphodiesterase IV | |
DE69721229D1 (de) | Reversibles einsteckschloss | |
ZA200203316B (en) | New use and novel n-azabicyclo-amide derivatives. | |
HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
DE10082535T1 (de) | Polyacetal-Blockcopolymere | |
ZA200204390B (en) | Caspase inhibitors and uses thereof. | |
TR199800117A3 (tr) | Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi. | |
HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
HK1039124A1 (en) | Phthalzaine derivatives phosphodiesterase 4 inhibitors. | |
NO20013237L (no) | 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater | |
DK1106607T3 (da) | Uracilforbindelser og anvendelse deraf | |
HU0001396D0 (en) | 3-amino-3-arylpropan-1-al derivatives and their use | |
NO986174L (no) | Triazinderivater og anvendelse derav | |
EP1210084A4 (en) | PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE | |
DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
MXPA02005070A (es) | 1-benzazepinas sustituidas y derivados de las mismas. | |
EE04494B1 (et) | 1-oksa-, asa- ja tianaftaleen-2-oon biseetrid fosfolambaani inhibiitoritena | |
IT1299133B1 (it) | Accessorio per orecchie, in particolare orecchino. | |
ATA185596A (de) | Schmuckstück | |
GB9929581D0 (en) | Comjpositions and their use | |
ES1033258Y (es) | Collarin bisagra perfeccionado. | |
DE29721423U1 (de) | Sicherheitstasche | |
ZA986484B (en) | Levobupivacaine and its use. | |
ZA986485B (en) | Levobupivacaine and its use. |